{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:59:56Z","timestamp":1785214796199,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R00DK136971"],"award-info":[{"award-number":["R00DK136971"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Stem cell-derived organoids are promising platforms for therapeutic screening in inflammatory bowel disease (IBD), but identifying functional organoid readouts with translational utility is challenging. Colon epithelial organoids from patients with ulcerative colitis (UC) overexpress chemokines CXCL1, CXCL11, CCL2, and CCL28, yet whether these epithelial inflammatory signatures correlate with disease activity and treatment response is unclear. This brief report explores whether organoid-retained chemokines correlate with disease activity and therapeutic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We interrogated three bulk and two single-cell transcriptomic datasets from IBD clinical trials encompassing anti-TNF\u03b1 and anti-integrin therapies to determine whether epithelial chemokines retained in UC organoids are associated with clinical response and distinguish treatment responders from non-responders to biologic therapy across multiple IBD patient cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In bulk transcriptomic data, CXCL1, CXCL11, and CCL2 were elevated in active UC and normalized only in patients achieving clinical remission, independent of therapy class, with persistent chemokine overexpression in non-responders. Linear regression analysis demonstrated that CXCL1 showed the strongest and most consistent association with Mayo clinical disease activity scores across independent cohorts. Single-cell analysis of epithelial cell types identified CXCL1 as the only chemokine significantly enriched in both enterocytes and LGR5-positive stem cells in UC. CXCL1 expression normalized in remission but remained elevated in non-remission patients, and this pattern was recapitulated in LGR5-high stem cell states. Epithelial CXCL1 expression was not associated with clinical remission in Crohn\u2019s disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CXCL1 is a remission-associated epithelial chemokine in UC and may represent a candidate biomarker and functional endpoint for epithelial-directed therapeutic screening using patient-derived organoid models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1904951","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:05Z","timestamp":1785212705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial CXCL1 tracks clinical remission in inflammatory bowel disease in a disease-specific manner"],"prefix":"10.3389","volume":"17","author":[{"given":"Sanmi E.","family":"Alake","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil H.","family":"Kadam","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Jester","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig L.","family":"Maynard","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babajide A.","family":"Ojo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otae026","article-title":"Real-world patterns and economic burden associated with treatment failure with advanced therapies in patients with moderate-to-severe ulcerative colitis","volume":"6","author":"Lee","year":"2024","journal-title":"Crohns Colitis 360"},{"key":"B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ibd\/izab161","article-title":"The promise of patient-derived colon organoids to model ulcerative colitis","volume":"28","author":"Ojo","year":"2022","journal-title":"Inflammation Bowel Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20480","article-title":"Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease","volume":"14","author":"Zimmerman","year":"2008","journal-title":"Inflammation Bowel Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.07.008","article-title":"Inflammation and the intestinal barrier: leukocyte-epithelial cell interactions, cell junction remodeling, and mucosal repair","volume":"151","author":"Luissint","year":"2016","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad142","article-title":"Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper","volume":"18","author":"Feakins","year":"2024","journal-title":"J Crohns Colitis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1101\/2024.08.22.609271","article-title":"Patient-derived colon epithelial organoids reveal lipid-related metabolic dysfunction in pediatric ulcerative colitis","volume":"16","author":"Ojo","year":"2025","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2016-312293","article-title":"Effect of vedolizumab (anti-\u03b14\u03b27-integrin) therapy on histological healing and mucosal gene expression in patients with UC","volume":"67","author":"Arijs","year":"2018","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01994-8","article-title":"A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease","volume":"25","author":"Thomas","year":"2024","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5555\/1953048.2078195","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","article-title":"Establishment, maintenance, and recall of inflammatory memory","volume":"28","author":"Larsen","year":"2021","journal-title":"Cell Stem Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1904951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:25:07Z","timestamp":1785212707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1904951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":15,"alternative-id":["10.3389\/fimmu.2026.1904951"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1904951","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"1904951"}}